Submitted by Anonymous (not verified) on 8 October 2025 - 14:52
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 7, Status: Authorised